Tanucan, Felipe B.

HRN: 21-91-84  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/17/2022
CEFTAZIDIME 1GM (VIAL)
10/17/2022
10/24/2022
IV
1gram
Q8hrs
CAP
Waiting Final Action 
10/21/2022
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
10/21/2022
10/28/2022
IVTT
750mg
Q8
Abscess Formation Of The Liver
Waiting Final Action 
10/23/2022
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
10/23/2022
10/29/2022
IV
1.5gram
Q6hrs As IV Infusion
CAP-MR; S/P CTT
Waiting Final Action 
10/24/2022
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
10/24/2022
10/31/2022
IV INFUSION
4.5g
Q8
Pulmonary Infection/ Infiltrates
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: